로딩 중…
StockDiggingStockDigging

Cell Bio Human Tech Co.,Ltd

318160· KOSDAQ
₩5,830-1.85%
2026-06-19

Price Chart

Cell Bio Human Tech Co.,Ltd-22.16%

Financials

Investment Metrics(as of 2026-06-19)

MetricValue
Size
Market Cap54.44B KRW
Revenue55.53B KRW
Net Income2.65B KRW
Total Assets90.41B KRW
Net Assets61.21B KRW
Employees58
Value
P/E20.56x
P/B0.89x
PEG0.63x
P/S0.98x
EV/EBITDA46.66x
FCF Yield-9.46%
Profitability
ROE4.32%
ROA2.93%
Op. Margin2.17%
Revenue Growth53.80%
Earnings Growth32.40%
Financial Health
Debt Ratio147.70%
Total Debt20.58B KRW
FCF-5.15B KRW
Cash18.70B KRW
Current Ratio2.43x
Net Debt/EBITDA1.55x
Performance
1Y Return-22.16%
1M Return-3.80%
From 52W High-49.35%
1Y MDD-52.64%
Trading
Volume30,434 shares
Foreign Own.4.71%
Per Share
EPS994 KRW
BPS7,048 KRW

Company Info

CEO 이권선
Employees 58
Founded 2015
HQ 경기도 안양시, KR

CellBioHumanTech was established in 2015 and listed on the KOSDAQ market in 2023. The company develops, manufactures, and supplies mask pack materials such as PT CELL, SEMI GEL, S Cell, and NC Cell, and is expanding into patches and wound dressings. It achieves cost savings and quality enhancement by directly producing non-woven fabrics at its Vietnam local subsidiary. CellBioHumanTech is expanding its global market presence through new material development and pursuing entry into the medical field with wound dressing development. CellBioHumanTech is headquartered in Anyang-si, Gyeonggi-do.